logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Malcolm Stuart Nobbs

This inventor holds 12 USPTO granted patents, plus 2 CIPO patents. Top assignees: Glaxo Wellcome Inc., Smithkline Beecham Corporation, Burroughs Wellcome Co.. Active years: 1992-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Malcolm Stuart Nobbs. Retrieved from https://idiyas.com/inventor/malcolm-stuart-nobbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 75.0


Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 150(Granted Patents)


Location History:

  • Beckenham, GB (1992 - 1998)
  • Hitchin, GB (2001 - 2002)
  • Stevenage, GB (2000 - 2003)

Company Filing History:

goldMedal8 out of 281 
 
Glaxo Wellcome Inc.
 patents
silverMedal3 out of 2,198 
 
Smithkline Beecham Corporation
 patents
bronzeMedal1 out of 521 
 
Burroughs Wellcome Co.
 patents

Years Active: 1992-2003

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 6599905 - Pyrazine compounds (2003-07-29),
2. 6548507 - Medical use (2003-04-15),
3. 6465461 - Triazine compounds for treatment of CNS disorders (2002-10-15),
4. 6265405 - Triazine compounds for treatment of CNS disorders (2001-07-24),
5. 6255307 - Pyrazine compounds (2001-07-03),
6. 6124308 - Optically active phenyl pyrimidine derivatives as analgesic agent (2000-09-26),
7. 5712276 - 2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines (1998-01-27),
8. 5684005 - Pharmacologically active CNS compounds (1997-11-04),
9. 5635507 - Pharmacologically active CNS compounds (1997-06-03),
10. 5597828 - Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidines which (1997-01-28),
11. 5587380 - Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines (1996-12-24),
12. 5136080 - Nitrile compounds (1992-08-04),

Title: The Innovations of Malcolm Stuart Nobbs

Introduction

Malcolm Stuart Nobbs is a notable inventor based in Stevenage, GB. He holds a total of 12 patents, showcasing his significant contributions to the field of medical science. His work primarily focuses on the development of innovative solutions for various health-related issues.

Latest Patents

One of his latest patents involves pyrazine compounds for medical use. This invention relates to the use of sodium channel antagonists in the treatment of diseases that are mediated by, or exacerbated by, neuronal apoptosis, particularly sensory neuronal apoptosis. This advancement has the potential to impact the treatment of various neurological conditions.

Career Highlights

Throughout his career, Malcolm has worked with prominent companies such as Glaxo Wellcome Inc. and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Malcolm has collaborated with esteemed colleagues, including Alistair A Miller and Richard M Hyde. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Malcolm Stuart Nobbs is a distinguished inventor whose work in medical science continues to make a significant impact. His innovative patents and collaborations highlight his dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…